UC Berkeley scientists are using a new CRISPR delivery system to more safely correct the mutated dystrophin gene in mouse models of DMD.
Scientists at Baylor have discovered that when they silence a signaling pathway in the body called Hippo, they can reverse heart failure in mice.
This past week ushered in new developments in the fight against retinitis pigmentosa, heart failure and pancreatic cancer.
Two commonly mutated genes in lung cancer may make some tumor cells especially vulnerable to an experimental drug from Calithera Biosciences.
Scientists at Yale believe they’ve found an immune connection to the inability to burn belly fat—and a possible solution.
Johns Hopkins researchers are altering the gut microbiome of mosquitoes to reduce the spread of malaria.
Two sets of researchers announced progress this week advancing research aimed at targeting addiction centers in the brain.
This past week saw new discoveries in treating heart failure, targeting Zika and dengue with one drug and inhibiting a cancer-promoting enzyme.
A new test quickly shows if an antibiotic fights a given infection, which can reduce improperly prescribed antibiotics.
With some tweaks, a gene therapy delivered to the liver could become a new treatment for multiple sclerosis.